FIGO stage IIIC endometrial carcinoma: Prognostic factors and outcomes
Hoekstra AV et al. - Endometrial cancer patients with FIGO stage IIIC had a 5-year OS of 61.3%, a RFS of 58.0% and a DSS of 71.9% in this series. Because of the high proportion of distant sites of recurrence (71.4%), recurrence outside the radiation field (100%), and mortality after recurrence (86.3%), multimodality therapy should be considered. [more...]
|
|
|
